PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
29-Mar-2021 Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery University of Birmingham
29-Mar-2021 LEO Foundation and Nordic Capital partner up to further strengthen LEO Pharma’s leading position in medical dermatology Nordic Capital
29-Mar-2021 Amzell BV appoints new Chairman and CEO as its portfolio of product development candidates approach Phase 3 trials Amzell BV
29-Mar-2021 Qlucore announces major new release (3.7) with ChIP-seq and Biomarker support Qlucore
29-Mar-2021 Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases Augustine Therapeutics
29-Mar-2021 Sputnik V approved in Vietnam The Russian Direct Investment Fund
29-Mar-2021 DUNAD THERAPEUTICS EMERGES TO DEVELOP NEXT-GENERATION SMALL MOLECULE THERAPEUTICS BASED ON FIRST TUNEABLE TARGETED PROTEIN DEGRADATION TECHNOLOGY Dunad Therapeutics
29-Mar-2021 HAEMATO AG successfully completes capital increase HAEMATO AG
29-Mar-2021 Drivers and Restraints Impacting the Global Kaposi Sarcoma Treatment Market; CMI Reveals Insights upto 2026 CDN Newswire
29-Mar-2021 Scailyte and Geninus Announce a Strategic Partnership to Develop a Predictive Assay for Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients Newswire
29-Mar-2021 Yposkesi to give talk on gene therapy vectors at Virtual Cell & Gene Meeting on the Mediterranean, April 6 – 9, 2021 Andrew Lloyd Associates
29-Mar-2021 Pangaea Data appoints new CFO and three pharmaceutical experts as advisors Pangaea Data
29-Mar-2021 Amryt Receives Positive Feedback from the FDA on the Path Forward for Myalept® (metreleptin) Indication in Partial Lipodystrophy Amryt
29-Mar-2021 Ergomed plc - Audited Full Year Results for the year ended 31 December 2020 Ergomed
29-Mar-2021 Cell-Easy strengthens executive team with two new highly experienced members Andrew Lloyd Associates
29-Mar-2021 Second dose milestone as 2.5 million get top-up jab NHS England
29-Mar-2021 Independent Peer-Reviewed Study Validates Therapeutic Mode of Action of Cardior's First-in-Class Heart Failure Program Cardior Pharmaceuticals
29-Mar-2021 Cytel opens Solara to general release & launches new Trial Optimization Solution for Biotechs Cytel
29-Mar-2021 Dementia Drugs Market Business still promises 8.4% CAGR by 2026 | Coherent Market Insights CDN Newswire
29-Mar-2021 BioMed X Institute Launches New Global Call in Neuroscience in Collaboration with Boehringer Ingelheim B3C newswire